The Pastor

The three-day Gaza border clash between Israel and Islamic Jihad has come to an end with an Egyptian brokered ceasefire going into effect late Sunday evening. Objectively, Israel's Breaking Dawn counterinsurgency operation was a resounding success, with Israel achieving all its objectives and Islamic Jihad being left battered and bloodied.

The Palestinian Islamic Jihad is an Iranian proxy group with no political echelon. It is designated as a Foreign Terrorist Organization by the United States and most of the free world. Unlike Hamas, which is also an Iranian proxy and a terrorist organization, Islamic Jihad has no community roots and does not partake in any Palestinian political processes. The relationship between Hamas and Islamic Jihad is part symbiotic and part adversarial. Hamas refrained from firing rockets at Israel in this round and Israel reciprocated in kind.

Islamic Jihad's main military presence is in Gaza, but the group also maintains cells in Judea & Samaria (also referred to as the West Bank). Last week, Israel succeeded in nabbing Islamic Jihad's West Bank chieftain, Bassem Saadi, and his deputy, Ashraf al-Jada, in a daring joint operation carried out by the Shin Bet, the Israel Defense Forces and the Border Police.

Nasrallah Once Again Provoking War With Israel | FrontpageMag

https://www.frontpagemag.com/fpm/2022/08/nasrallah-once-again-provoking-war-israel-joseph-puder/

Hassan Nasrallah, the chief of the terrorist Lebanese Hezbollah organization is at it again, seeking to challenge Israel to a fight. He is repeating the same bravado as he did in 2006, which led to the Second Lebanon War. In 2006, Nasrallah underestimated Israel's response to his provocations. In a cross-border raid on July 12, 2006, Hezbollah terrorists lobbed an anti-tank missile at two armored Israeli Humvees patrolling the Israeli side of the border fence. The ambush left three Israeli soldiers dead. Two Israeli soldiers: Ehud Goldwasser and Eldad Regev were taken prisoners, and ultimately murdered.

In July 2022, Nasrallah warned that Israel and foreign companies would not be allowed to start drilling at the Karish gas field unless Israel agreed on a maritime border with Lebanon. In addition, he warned that if Israel began production, it would escalate into a conflict as early as September, and he did not rule out the possibility of a full-scale war with Israel. Earlier in July, Hezbollah unleashed two drones targeting the Karish gas field; they were downed by Israeli Navy and Air Force units.

RADIO: The Yeshua Protocol - by Carl Gallups - Amazon top 60 bestselling author

http://www.carlgallups.com/protocol/

Wednesday, August 10, 2022

Historic Valley forge prophecy given to General George Washington

https://www.ushistory.org/valleyforge/washington/vision.html

'One size fits all' pill for cancer treatment may be on horizon

https://www.msn.com/en-us/health/medical/one-size-fits-all-pill-for-cancer-treatment-may-be-on-horizon/ar-AAY2zDk?

A protein that destroys hard to treat cancers has been discovered by scientists - offering hope of effective new treatments.

Experiments on mice and human tissue found it is effective against the most aggressive tumors.

They include those of the breast, pancreas, ovaries and brain. The compound, known as ERX-41, leaves healthy tissue unscathed.

It is one of the most promising breakthroughs to date - offering hope of a "one size fits al"' pill that was once thought impossible.

Results were so encouraging clinical trials are expected to begin in the next few months.

Lead author Professor Ratna Vadlamudi, of the University of Texas, said: "We identified a critical vulnerability in multiple cancers and have validated our findings in multiple cancer cell types and animal models.

"The range of cell lines and xenografts in which the compound has been shown to work is compelling and indicates that it is targeting a fundamental vulnerability in cancer cells."

Xenografts are human tumors grown in mouse models for research purposes. The findings could lead to exciting drugs for cancers that have few effective treatments.